P < 0.05 was considered significant. Based on the final diagnosis, 78 enrolled participants were divided into two groups: MG-132 mw a TB group (n = 58) with a diagnosis of confirmed or probable tuberculous pleurisy, and a non-TB group (n = 20) with diagnosis of other non-TB diseases. In the TB group, patients with confirmed tuberculous pleurisy (n = 17) were culture-positive

for M.tb of pleural fluid (n = 5) and/or histologically confirmed to have TB by pleural biopsy under the thoracoscope (n = 14). Patients with probable tuberculous pleurisy (n = 41) were sputum culture-positive for M.tb (n = 11), or positively responded to anti-TB medications without other possible causes of pleural effusion (n = 30). The median age of enrolled patients was 49 years old and 20 of the 78 were men (25.6%). The etiologies of non-TB

pleural effusion included pulmonary adenocarcinoma (n = 6, five males, 47–89 years old), small-cell lung cancer (n = 1, female, 52 years old), pulmonary low differentiated squamous cell carcinoma (n = 1, male, 76 years old), mesothelioma of pleura (n = 1, female, 56 years old), bacterial pneumonia (n = 6, six males, 33–91 years old), liver cirrhosis (n = 1, female, 46 years old), rheumatoid honeycombing (n = 1, female, 57 years old), pulmonary lymphangioleiomyomatosis (LAM; n = 1, female, AZD1208 25 years old) and non-TB pleural effusion of an undetermined origin (n = 2, one male, 34–46 years old; Table 1). All 78 enrolled participants were tested with QFT-GIT and TST. The positive rates of QFT-GIT and TST in the TB group were 93.1% (54/58) and 68.5% (37/54) (P = 0.013), respectively, whereas the negative rates of QFT-GIT and TST in the non-TB group (n = 20) were 90.0% (18/20) and 86.7%

(13/15), respectively (P = 1.000; Fig. 1). Furthermore, the IFN-γ secretions in response to PHA were comparable in two groups, whereas that in response to TB antigen in the TB group were significantly higher than in the non-TB group (P < 0.0001; Fig. 2). The receiver operating curve (ROC) analysis showed that the area under the ROC (AUC) of QFT-GIT and TST for TB diagnosis was 0.913 and 0.812, respectively (P = 0.152, Fig. 3). Thus, QFT-GIT was more sensitive and specific than TST Chlormezanone for diagnosing TB. In addition, 78 samples of pleural fluid pellet suspension were amplified by nested-PCR for M.tb detection. Among 58 patients in the TB group, 55 (94.8%) were positive, whereas only two (10.0%) were positive among the 20 patients in the non-TB group; the sensitivity and specificity of nested-PCR were 94.8% and 90.0%, respectively. Compared with conventional AFB and M.tb culture, the specificity of nested-PCR was comparable with TST and QFT-GIT (90.0% vs. 86.7% and 90.0%, respectively), whereas the sensitivities of nested-PCR and QFT-GIT were comparable, and were much higher than TST, AFB and M.tb culture (Fig. 4).